Meredith Buxton Discusses the I-SPY 2 Trial

April 26, 2016
Meredith Buxton, PhD

Meredith Buxton, PhD, University of California San Francisco, discusses the I-SPY 2 trial, for which she is the executive director.

Meredith Buxton, PhD, University of California San Francisco, discusses the I-SPY 2 trial, for which she is the executive director.

The goal of I-SPY 2 is to test new agents, like immunotherapies, and ultimately get them to patients sooner. While it is currently only being used in the breast cancer domain, Buxton noted that hopefully other cancer types will also join in the trial.